TAUNS Laboratories,Inc. (TYO:197A)
489.00
-2.00 (-0.41%)
Jun 4, 2026, 3:30 PM JST
TAUNS Laboratories,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Cash & Equivalents | 4,255 | 9,267 | 9,425 | 1,244 |
Cash & Short-Term Investments | 4,255 | 9,267 | 9,425 | 1,244 |
Cash Growth | -54.85% | -1.68% | 657.40% | - |
Accounts Receivable | 7,207 | 247.78 | 2,707 | 3,051 |
Other Receivables | - | - | 16.41 | 429.41 |
Receivables | 7,207 | 247.78 | 2,723 | 3,481 |
Inventory | 6,433 | 5,884 | 4,717 | 4,587 |
Prepaid Expenses | - | 27.98 | 30.78 | 19.12 |
Other Current Assets | 1,013 | 50.69 | 19.32 | 125.83 |
Total Current Assets | 18,908 | 15,477 | 16,916 | 9,457 |
Property, Plant & Equipment | 15,524 | 12,279 | 7,905 | 4,402 |
Long-Term Investments | 5,404 | 4,889 | 686.51 | 487.69 |
Other Intangible Assets | 3,790 | 3,837 | 3,721 | 3,910 |
Other Long-Term Assets | 571.39 | 33.27 | 33.01 | 75.29 |
Total Assets | 44,199 | 36,515 | 29,261 | 18,332 |
Accounts Payable | 1,069 | 1,199 | 1,483 | 1,143 |
Accrued Expenses | 66.66 | 388.92 | 1,010 | 267.98 |
Short-Term Debt | 7,500 | 4,500 | 4,500 | 3,500 |
Current Portion of Long-Term Debt | 1,783 | 1,115 | 732 | 732 |
Current Income Taxes Payable | 898.85 | 842.29 | 1,706 | - |
Current Unearned Revenue | - | 78.61 | - | - |
Other Current Liabilities | 1,832 | 1,406 | 1,044 | 874.56 |
Total Current Liabilities | 13,149 | 9,530 | 10,474 | 6,518 |
Long-Term Debt | 12,868 | 8,809 | 4,307 | 2,236 |
Pension & Post-Retirement Benefits | 207.65 | 190.36 | 181.63 | 154.21 |
Long-Term Deferred Tax Liabilities | 555.99 | 556.3 | 619.49 | 922.12 |
Other Long-Term Liabilities | 12 | 12.01 | 12 | 12 |
Total Liabilities | 26,793 | 19,098 | 15,595 | 9,842 |
Common Stock | 392.12 | 289.77 | 200 | 100 |
Additional Paid-In Capital | 2,875 | 2,773 | 2,683 | 2,783 |
Retained Earnings | 14,102 | 13,308 | 10,778 | 5,604 |
Comprehensive Income & Other | 36.14 | 1,047 | 5.61 | 2.81 |
Shareholders' Equity | 17,406 | 17,418 | 13,667 | 8,490 |
Total Liabilities & Equity | 44,199 | 36,515 | 29,261 | 18,332 |
Total Debt | 22,151 | 14,424 | 9,539 | 6,468 |
Net Cash (Debt) | -17,896 | -5,157 | -114.11 | -5,224 |
Net Cash Per Share | -166.68 | -48.10 | -1.07 | -52.24 |
Filing Date Shares Outstanding | 101.78 | 102.99 | 100 | 100 |
Total Common Shares Outstanding | 101.78 | 102.99 | 100 | 100 |
Working Capital | 5,759 | 5,947 | 6,441 | 2,939 |
Book Value Per Share | 171.01 | 169.12 | 136.67 | 84.90 |
Tangible Book Value | 13,616 | 13,581 | 9,946 | 4,580 |
Tangible Book Value Per Share | 133.77 | 131.86 | 99.46 | 45.80 |
Land | - | 1,735 | 1,735 | 1,735 |
Buildings | - | 1,342 | 1,110 | 1,036 |
Machinery | - | 2,898 | 2,729 | 2,511 |
Construction In Progress | - | 8,213 | 3,973 | 497.14 |